Myocardial perfusion PET is a well established technique for assessing obstructive coronary artery and coronary microvascular diseases. It has been shown to be superior to SPECT imaging in image quality, prognostic information, scan time and lower radiation dose for both the patient and operators. Through the creation of dynamic images, PET also provides the ability […]
Dr Ian Armstrong
Manchester University NHS Foundation Trust
PETCT plays a vital role in patient management, primarily in oncology using FDG, and there has been a wide expansion of PETCT provision throughout the UK. Demand for the service has increased year-on-year, and emerging tracers such as Ga-68 PSMA for prostate imaging and new non-oncology indications should continue to see the service expand. In […]
Dr Ian Armstrong
Manchester University NHS Foundation Trust
The growing demand for PETCT in oncology posed a challenge for Central Manchester University Hospitals NHS Foundation Trust, with a projected 14 per cent annual increase in scanning numbers. Its use of F18 Fludeoxyglucose (18F-FDG) in oncology produced reliable results, but there was a clear need to increase efficiency to accommodate this increasing demand. Additionally, […]
Ian S Armstrong
Central Manchester University Hospital
Positron emission tomography (PET) has made a valuable contribution to the staging of malignancy for well over a decade. This time period has seen a rapid evolution from 2D PET to 3D PET, to the current 3D extended axial field of view PET systems with integral multi-slice CT. This evolution has been accompanied by significant […]
Ian S Armstrong, Dr Jackie M James
Central Manchester University Hospitals NHS Trust